Florida Opportunity Fund
Orlando, Florida, United StatesFounded 2007
The Florida Opportunity Fund primarily invests in a diversified portfolio of seed and early-stage venture capital funds that target investment opportunities within Florida. Its strategy aims to increase the availability of capital for emerging companies in strategic sectors such as life sciences, information technology, and advanced manufacturing, and it also makes direct investments in Florida businesses and infrastructure projects.
33% of their portfolio is in Healthcare. Their most common stage is seed (67% of deals). Average disclosed round size is $16.5M (across 8 rounds with reported amounts).
Portfolio
9
Fund Size
$108M
Top Stage
Seed
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Urban SDK | Growth | $65M | Feb 2026 |
 Beycome | Seed | $2.5M | Dec 2025 |
 Worth | Seed | $20M | Mar 2025 |
 Myosin Therapeutics Inc. | Seed | $3M | Feb 2025 |
 Propense.ai | Seed | $3M | Mar 2024 |
 HealthSnap | Series B | $25M | Feb 2024 |
 Cyrano Therapeutics, Inc. | Series B | $9M | Jan 2024 |
| Myosin Therapeutics Inc. | Seed | — | Mar 2023 |
| Urban SDK | Seed | $4.5M | Jan 2022 |
Top Co-Investors
DeepWork Capital5 shared
Florida Funders2 shared
Pivot Investment Partners1 shared
Kima Ventures1 shared
Founders Future1 shared
TTV Capital1 shared
Ingeborg Investments1 shared
Mayo Clinic1 shared
Sontag Innovation Fund1 shared
Harlem Capital1 shared
Operator Collective1 shared
Techstars1 shared
Sands Capital1 shared
Comcast1 shared
Riverwood Capital1 shared
Last updated: 21 April 2026